EcoDrugPlus

Tubulin Beta Class I

Ensembl ID : ENSCAFG00020018340
Gene Symbol: TUBB
3 Cross references
114 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSCAFG00020007703
Gene Symbol: TP53
3 Cross references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSCAFG00020016835
Gene Symbol: TYR
3 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSCAFG00020017377
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSCAFG00020024459
Gene Symbol: TYK2
3 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCAFG00020017639
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Utrophin

Ensembl ID : ENSCAFG00020001787
Gene Symbol: UTRN
3 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCAFG00020012066
Gene Symbol: VEGFA
3 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCAFG00020011290
Gene Symbol: VDR
3 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSCAFG00020018154
Gene Symbol: VKORC1
3 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSCAFG00020023641
Gene Symbol: XDH
3 Cross references
210 Possible Orthologues:

Ensembl ID : ENSCAFG00020010362
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).